Physician profile
Katelyn Erwin
NPI 1205445863
$872.47
in general payments reported to CMS, 2019-2025
17 companies · $172 in 2025
The $172 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $318 · 2022: $249 · 2023: $60.25 · 2024: $74.23 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $306.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $197.03 | 2021-2023 | Rybelsus, Ozempic |
| Abbvie INC. | $177.52 | 2021-2024 | |
| Lilly USA, LLC | $88.42 | 2021-2023 | Mounjaro |
| Otsuka America Pharmaceutical, INC. | $87.17 | 2021-2025 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $65.35 | 2021-2024 | Xifaxan |
| Medtronic, INC. | $48.86 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $33.31 | 2025 | Austedo Xr, Uzedy |
| Vanda Pharmaceuticals INC. | $27.47 | 2025 | Fanapt |
| Astellas Pharma US INC | $21.93 | 2025 | Veozah |
| Hologic Sales and Service, LLC | $19.38 | 2024 | Aptima, Thinprep 2000 Processor |
| Organon LLC | $19.11 | 2024 | |
| Janssen Pharmaceuticals, INC | $17.86 | 2025 | Spravato |
| Vertex Pharmaceuticals Incorporated | $17.36 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.66 | 2022 | |
| Dexcom, INC. | $13.40 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $11.37 | 2021 | |
| Axsome Therapeutics, INC. | $11.27 | 2025 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katelyn Erwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.